Lanadelumab wykazuje wysoką skuteczność w zmniejszaniu częstości napadów obrzęku naczynioruchowego u pacjentów z ciężkim HAE w warunkach codziennej praktyki klinicznej.

Copyright of Paediatrics & Family Medicine / Pediatria i Medycyna Rodzinna is the property of Medical Communications Sp. z o.o. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)